|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myo- cardial infarctionA randomized, placebo-controlled, double-blind study (RUSSLAN) 显示文摘 | Moiseyev VS Poder P Andrejevs N | 2002 | Eur Heart2002，23，18： | 1 |
| 2 | Safety and efficacy of a novel calcium sensitizer,levosimendan,in patients with left ventricular failure due to an acute myocardial infarction:a randomized,placebo-controlled,double-blind study (RUSSLAN)显示文摘 | Moiseyev VS Poder P Andrejevs N | 2002 | Eur Heart J2002，23，： | 1 |
| 3 | On behalf of RUSSIAN investigators: Randomized study on safety and effectiveness of levosimendan in patients with left ventricular heart failure after an acute myocardial infarction (the RUSSIAN study) 显示文摘 | Moiseyev VS Poder P Andrejevs N | 2002 | Eur Heart J2002，23，18： | 1 |
| 4 | Safety and efficacy of a novel calcium sensitizer, levosimendan in patients with left ventricuhr faihre due to an acute myocardial infarction: a randomized, placebacontrolled, double, blind study (RUSSLAN) 显示文摘 | MOISEYEV VS PODER P ANDREVS N | 2002 | Eur Heart J2002，23，18： | 1 |
| 5 | Safety and efficacy of a novel calcium sensitizer,levosimendan,in patients with left ventricular failure due to an acute myocardial infarction:A randomized,placebo-controlled,doubleblind study(RUSSLAN)显示文摘 | Moiseyev VS Poder P Andrejevs N | 2002 | Eur Heart J2002，23，18： | 1 |
| 6 | Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infaretion:a randomized, place bocontrolled, double-blind study ( RUSS- LAN) 显示文摘 | Moiseyev VS Poder P Andrejevs N | 2002 | Eur Heart J2002，23，18： | 1 |
| 7 | Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction显示文摘 | Moiseyev VS Poder P Andrejevs N etal | 2002 | Eur Heart J2002，23，： | 1 |
| 8 | Safety and efficacy of a novel calcium sensitizer,levosimendan,in patients with left ventrieular failure due to an acute myocardial infarction : A randomized, placebo-comrolled, doubleblind study ( RUSSLAN ) 显示文摘 | Moiseyev VS Poder P Andrejevs N | 2002 | Eur Heart J2002，23，18： | 1 |
| 9 | Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction:Arandomized, placebo-controlled, double-blind study ( RUSSLAN )显示文摘 | Moiseyev VS Poder P Andrejevs N | 2002 | Eur Heart J2002，23，18： | 1 |
| 10 | Safety and efficacy of a novel calcium sensitizer,levosimendan,in patients with left ventricular failure due to an acute myocardial infarction : a randomized, placebo-controlled, double-blind study (RUSSLAN) 显示文摘 | Moiseyev VS Poder P Andrejevs N | 2002 | Eur Heart J2002，23，18： | 1 |
| 11 | Safety and efficacy of a novel cal- cium sensitizer, levosimendan in patients with left ventricular failure due to an acute myocardial infarction: a randomized, placebo-controlled, double-blind study (RUSSLAN) 显示文摘 | Moiseyev VS Poder P Andrejevs N | 2002 | Eur Heart J2002，23，18： | 1 |
| 12 | Safety and effica- cy of a novel calcium sensitizer, levosimendan in patients with left ventricular failure due to an acute myocardial infarction: a randomized, placebo-controlled, double blind study (RUS- SLAN) 显示文摘 | Moiseyev VS Poder P Andrejevs N | 2002 | Eur Heart J2002，23，： | 1 |
| 13 | Safety and efficacy of a novel calcium sensitizer,levosimendan,in patients with left ventricular failure due to an acute myocardial infarction显示文摘 | MOISEYEV VS PODER P ANDREJEVS N | 2002 | Eur Heart J2002，23，18： | 1 |
| 14 | Safety and efficacy of a novel calcium sensitizer,levosimendan,in patients with left ventricular failure due to an acute myocardial infarction:a randomized,placebo-controlled,double-blind study(RUSSLAN)显示文摘 | Moiseyev VS Poder P Andrejevs N | 2002 | Eur Heart J2002，23，： | 1 |
| 15 | Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction: A ran- domized, placebo - controlled, double - blind study ( RUSS- LAN) 显示文摘 | Moiseyev VS Poder P Andrejevs N | 2002 | Eur Heart J2002，23，18： | 1 |
| 16 | Safety and efficacy of a novel calcium sensitizer,levosimendan,in patients with left ventricular failure due to an acute myocardial infarction : a randomized, placebo-controlled, double-blind study (RUSSLAN) 显示文摘 | Moiseyev VS Poder P Andrejevs N | 2002 | Eur Heart J2002，23，18： | 1 |
| 17 | Safety and eficaey of a novel calcium sensitizer, levosimendan, in patients with leventrieular failure due to an acute myocardial infarction: Arandomized, placebo- controlled, double-blind study (RUSSLAN) 显示文摘 | Moiseyev VS Poder P Andrejevs N | 2002 | Eur Heart J2002，23，18： | 1 |
| 18 | Safety and efficacy of a novel calcium sensitizer,Ievosimendan in patients with left ventricular failure due to an acute myocardial infarction:A randomized,placebo-controlled,double-blind study(RUSSLAN)显示文摘 | Moiseyev VS Poder P Andrejevs N | 2002 | Eur Heart J2002，23，： | 1 |
| 19 | Safety and efficacy of a novel calcium sensitizer, levosimendan,in patientswith left ventricular failure due to an acutemyocardial infarction : a randomized, placebo-controlled, double-blind study ( RUSSLAN ) 显示文摘 | MOISEYEV VS PODER P ANDREJEVS N | 2002 | EurHeart J2002，23，18： | 1 |
| 20 | Evaluation of a comprehensive tobacco control project targeting Arabic-speakers residing in south west Sydney, Australia 显示文摘 | Perusco A Poder N Mohsin M | 2010 | Health Promot Int2010，25，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员